Abstract:Ovarian cancer is a common gynecological tumor with the highest mortality rate, which has repeated recurrence and poor efficacy. It is an urgent clinical problem to be solved. Ovarian cancer is expected to improve the survival time and quality of life of patients with whole-course management based on the progress of targeted and immunotherapy, the diagnosis and thinking of recurrent ovarian cancer are initiated, and the standardized management of ovarian cancer throughout its life cycle is further proposed.
